bf/NASDAQ:GLSI_icon.png

NASDAQ:GLSI

Greenwich LifeSciences, Inc.

  • Stock

USD

Last Close

16.62

26/07 20:00

Market Cap

203.12M

Beta: 3.53

Volume Today

34.03K

Avg: 47.81K

PE Ratio

−13.47

PFCF: −17.98

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-1.69M
-
-3.43M
102.72%
-1.86M
45.61%
-4.57M
145.34%
-7.83M
71.21%
-8.89M
13.63%
depreciation and amortization
3.61K
-
3.61K
0%
3.61K
0.06%
3.61K
0.08%
3.61K
0%
3.61K
0%
deferred income tax
-777.76K
-
-1.19M
53.59%
-1.75M
46.59%
stock based compensation
194.94K
-
677.99K
247.79%
660.58K
2.57%
1.74M
163.99%
2.38M
36.37%
change in working capital
1.57M
-
2.93M
86.72%
28.40K
99.03%
-385.17K
1,456.08%
-122.27K
68.26%
35.47K
129.01%
accounts receivables
inventory
accounts payables
80.97K
-
393.40K
385.88%
-92.55K
123.53%
-526.73K
469.13%
35.47K
-
other working capital
1.49M
-
2.54M
70.46%
120.95K
95.24%
141.57K
17.04%
-122.27K
186.37%
-35.47K
70.99%
other non cash items
-2
-
777.76K
38,887,900%
1.19M
53.59%
1.75M
46.59%
31.50K
98.20%
net cash provided by operating activities
-114.95K
-
-293.27K
155.12%
-1.15M
293.14%
-4.29M
272.22%
-6.20M
44.47%
-6.48M
4.49%
investments in property plant and equipment
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites
debt repayment
-360K
-
common stock issued
30.17M
-
3.11M
89.69%
common stock repurchased
-7.54M
-
dividends paid
other financing activites
200K
-
215K
7.50%
-360K
267.44%
-275.15K
23.57%
net cash used provided by financing activities
200K
-
215K
7.50%
29.81M
13,763.49%
2.84M
90.49%
-7.54M
365.79%
effect of forex changes on cash
net change in cash
85.05K
-
-78.27K
192.03%
28.65M
36,709.99%
-1.46M
105.08%
-13.74M
843.35%
-6.48M
52.84%
cash at beginning of period
54
-
85.10K
157,496.30%
6.83K
91.97%
28.66M
419,217.85%
27.20M
5.08%
13.47M
50.49%
cash at end of period
85.10K
-
6.83K
91.97%
28.66M
419,217.85%
27.20M
5.08%
13.47M
50.49%
6.99M
48.10%
operating cash flow
-114.95K
-
-293.27K
155.12%
-1.15M
293.14%
-4.29M
272.22%
-6.20M
44.47%
-6.48M
4.49%
capital expenditure
free cash flow
-114.95K
-
-293.27K
155.12%
-1.15M
293.14%
-4.29M
272.22%
-6.20M
44.47%
-6.48M
4.49%

All numbers in USD (except ratios and percentages)